Prevention of glucocorticoid-induced skin atrophy

Details Prevention of glucocorticoid-induced skin atrophy Prevention of glucocorticoid-induced skin atrophy

1986-11-03

1989-12-26

Schenkman, Leonard

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

514180, 514381, 514438, 514532, 514559, 514569, 514570, 514617, 514725, 514732, 514922, A61K 3107, A61K 3156

Patent

active

048898473

ABSTRACT:
The present invention is directed to the topical administration of a retinoid-containing pharmaceutical composition for the prevention of glucocorticoid-induced skin atrophy.

REFERENCES:
patent: 3729568 (1973-04-01), Kligman
patent: 4126643 (1978-11-01), Gander et al.
patent: 4487782 (1984-12-01), Mezick

Affiliated with

Also associated with

Rating

Prevention of glucocorticoid-induced skin atrophy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prevention of glucocorticoid-induced skin atrophy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prevention of glucocorticoid-induced skin atrophy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1577320